Travere Therapeutics
Price & Volume
Stats
See more52W Range | $12.91-$42.13 |
Market Cap | $3.4B |
Shares Short | 12M |
Financials
See moreRevenue (12 Mos) | $435.8M |
Revenue Growth (YoY) | 162.1% |
Gross Profit (12 Mos) | $215.2M |
Diluted EPS | -$1.03 |
News
See moreYahoo Finance • 6 days ago
Dow Jones Futures Fall After Christmas; Nvidia Makes Big Deal
Yahoo Finance • 6 days ago
Dow Jones Futures Open After Market Holiday; S&P 500 At Highs
Yahoo Finance • 7 days ago
Why Travere Therapeutics Stock Popped by Nearly 14% on Wednesday
Yahoo Finance • last month
Why IBD 50's No. 2 Stock, Travere Therapeutics, Has Doubled In 2025
About
CEO | Dr. Eric M. Dube Ph.D. |
Address | 3611 Valley Centre Drive, San Diego, CA, United States, 92130 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 385 |
